Recombinant Human BDH2 (N-6His)

Description

EnkiLife provides the Recombinant Human BDH2 (N-6His) protein,aslo know as 3-Hydroxybutyrate Dehydrogenase Type 2,Dehydrogenase/Reductase SDR Family Member 6,Oxidoreductase UCPA,R-Beta-Hydroxybutyrate Dehydrogenase,BDH2,DHRS6, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human 3-Hydroxybutyrate Dehydrogenase Type 2 is produced by our E.coli expression system and the target gene encoding Met1-Leu245 is expressed with a 6His tag at the N-terminus.Accession:AAH01953.1. Expression Host:E.coli.Species:Human.Predicted Molecular Mass:28.86 KDa. Background:3-Hydroxybutyrate Dehydrogenase Type 2 belongs to the short-chain dehydrogenases/reductases (SDR) family. 3-Hydroxybutyrate Dehydrogenase Type 2 may play an important role in the peripheral utilization of 3-hydroxybutyrate. The cytoplasmic localization with its high ratio of oxidized NAD+, the NAD+ dependence and the kinetic parameters of 3-Hydroxybutyrate Dehydrogenase Type 2 make it suitable to conbert high levels of circulating 3-hydroxybutyrate into acetoacetate.